Adalvo Partners With AmbioPharm For Several Complex Products
Development And Licensing Partnership Includes ‘Difficult-To-Make’ Peptide Products
• By Akriti Seth
Adalvo and AmbioPharm have partnered on a basket of difficult-to-make peptides with a potential market of $3bn • Source: Shutterstock 
